Allergic Rhinitis and Its Impact on Sleep by J. Rimmer & J. Hellgren
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Allergic Rhinitis and Its Impact on Sleep 
J. Rimmer1 and J. Hellgren2 
1Woolcock Institute and University of Sydney, Department of ENT, Sydney 




Allergic rhinitis affects a fifth of the population in industrialised countries and sleep 
disturbance has emerged as one of the major impacts of allergic rhinitis on patients. Sleep 
disturbances and its consequences on daytime sleepiness and fatigue affects the health 
related quality of life negatively and contributes significantly to patients’suffering and major 
health economic costs. Experimental studies have shown that sleep disturbances are 
induced when the nose is blocked with adhesive tape or petroleum jelly during sleep in 
healthy individuals. Nasal obstruction is the most commonly reported symptom by patients 
with allergic rhinitis and it causes an increased number of microarousals (short 
awakenings). Nasal obstruction is believed to be the most important mechanism behind poor 
sleep and daytime sleepiness in allergic rhinitis. Relieving nasal obstruction with nasal steroids 
significantly improves subjective sleep compared to placebo. Allergic rhinitis is present in a 
majority of patients with asthma. Identifying and treating allergic rhinitis improves sleep and 
the health related quality of life which reduces patient suffering and potentially saves 
significant health economic health costs. The present chapter reviews the current literature of 
allergic rhinitis and its impact on sleep and the health related quality of life. 
1.1 Abbreviations 
AR: allergic rhinitis 
PAR: perennial allergic rhinitis 
SAR: seasonal allergic rhinitis 
SDB: sleep disordered breathing 
RDS: rhinitis disturbed sleep 
1.2 Prevalence 
The prevalence of allergic rhinitis has steadily increased in developed countries since the 
industrial revolution and now affects 20-40% of the population (1,2). Studies suggest that 
allergic rhinitis and conjunctivitis are rare in infants but are estimated to affect around one 
in six children aged 6-7 years, one in ten children aged 13-14 years, 18% of those aged 15-34 
years and 10% of older adults aged 35-54 years. AR is more common than asthma and 
chronic rhinosinusitis. Symptoms generally persist for at least ten years, often longer (3). 







More than $6 billion was spent on prescription medications for AR in 2000 (5) in the USA. A 
specifically commissioned report in Australia estimated the total costs costs of Allergic 
disease (not asthma) including prescription medication to be $349 million in Australia in 
2007 (3). 
1.4 Symptoms 
Symptoms of AR include nasal blockage or congestion occurring in up to 85%, and this 
tends to be the dominant symptom in children (5). It is generally most troublesome in the 
early morning on waking which may relate to the circadian rhythm for cortisol although the 
peak in symptoms is delayed compared to that of nocturnal asthma (6am versus 4am) (6). 
Nasal obstruction is the symptom that relates most to impaired quality of life (7). In addition 
there is a direct relationship between sleep impairment and symptom severity ( 5, 8). Nasal 
obstruction has been shown to be an independent risk factor for OSAS (obstructive sleep 
apnoea syndrome) (9). Other symptoms include sneezing, pruritis, anterior rhinorrhoea, 
post nasal drip and these may also contribute to SDB. 
Numerous studies have shown that AR results in impaired QOL and affects numerous 
activities eg work productivity and attendance, physical activity, exam performance. How 
much of this is due to the disease itself or the accompanying SDB or both is unclear. 
Interestingly many patients report dissatisfaction with the effectiveness of therapy (10). 
1.5 Children and AR 
SDB is well documented to occur in children and adolescents with AR (5, 11) The most 
common symptom is nasal obstruction. In children there are typical appearances associated 
with AR including mouth breathing, allergic shiners, allergic crease, allergic facies and these 
may be reversed by treatment of the rhinitis. Rhinitis has frequently been considered to be a 
benign condition in children and one that does not need treating. However more recent data 
indicates that in addition to symptoms there may be deleterious effects of the condition on 
their performance. Specifically in children studies have shown reduced examination 
performance in the spring season and reduced participation in skill based, social and 
informal activities (12, 13). Habitual snoring is increased in children with AR (14) 
2. Sleep problems in AR 
Sleep disordered breathing is reported by subjects with allergic rhinitis versus controls 
including difficulty getting to sleep (24% versus 8%), waking during the night (31% versus 
13%) and poor sleep (26% versus 11%) (5, 15) Leger et al additionally noted early wakening 
in 29% of AR , feeling of lack of sleep in 63%, snoring 40%, insomnia 36%, OSAS 4% and also 
that there was a greater use of sedatives in the AR group (16). Poor sleep is associated with 
negative effects on mood, cognition and motor performance. A large epidemiological study 
of over 4900 subjects showed that AR subjects who reported nocturnal nasal congestion ≥ 5 
nights/month were more likely to be habitual snorers, experience excess daytime sleepiness 
or nonrestorative sleep (17). SDB is felt to relate to nasal obstruction but can also be caused 
by other symptoms eg rhinorrhea, pruritis and sneezing occurring during the night and also 
by the effects of inflammatory mediators. In addition commonly co-existing diseases such as 
asthma in which nocturnal asthma can be a significant symptom can disturb sleep. 
Nocturnal asthma is attributed to a circadian variation in airway physiology as well as the 
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effects of cytokine changes on sleep (see below).Eczema may also contribute to SDB with 
symptoms of pruritis often worse at night (18). 
Sleep impairment in AR has been demonstrated by means of questionnaires, actigraphy 
(19,20) and polysomnography (17, 21) 
The presence of abnormal sleep in association with AR categorises the disease as moderate 
to severe according to the ARIA classification of AR (Allergic Rhinitis and its Impact on 
Asthma) guidelines (Fig 1) (22 ) 
 
Intermittent symptoms  Persistent symptoms
 <4 days per week   >4 days per week 
 Or < 4 weeks   And > 4 weeks 
  
Mild  Moderate – severe (≥ 1 item) 
 Normal sleep   Abnormal sleep 
 Normal daily activities   Impairment of daily 
activities, sport, leisure 
 Normal work and school   Problems caused at school 
or work 
 No troublesome symptoms   Troublesome symptoms 
Fig. 1. ARIA classification of AR 
The average sleep duration of healthy adults is about 7 hours but surveys show that a 
significant % of the population (43%) achieve less than this (23) and that these subjects felt 
tired, performed inefficiently and reported feeling drowsy while driving. It has been 
estimated that 20% of all traffic accidents in industrialised societies are related to sleep 
disorders. 
Sleep disorders refers to a range of disorders including insomnia, OSAS, narcolepsy and 
idiopathic hypersomnolance, periodic limb disorders of sleep and restless leg syndrome. All 
of these primary sleep disorders are associated with excess daytime fatigue. SBD in AR 
includes insomnia and OSAS although recently a separate classification of RDS (rhinitis 
disturbed sleep) has been postulated (24). 
Insomnia is a subjective perception of the amount or quality of sleep. It can comprise 
delayed initiation of sleep, difficulty with sleep maintenance and early awakening. It is 
associated with impaired QOL as demonstrated by reduced daytime alertness, lethargy, 
reduced cognitive functioning and altered emotional states. The 2008 NSF Sleep in America 
Poll found that 11% of the population described insomnia (26% difficulty falling asleep, 42% 
waking during the night, 29% woken early and unable to return to sleep)(25). Subjects with 
insomnia have a higher rate of traffic accidents: 5% versus 2% of normal sleepers. 
OSAS in the general population is estimated at 2-4% and results in snoring, severe daytime 
sleepiness and increased risk of traffic accidents. The risk of RTA for OSAS is 12 times 
greater than controls and also higher than insomniacs. There is a direct relationship between 
the apnoea-hypopnoea index and crash risk. 
However despite the documented impaired cognition and presence of SDB in AR no studies 






RDS is a term that has been suggested to separate the effects of nasal obstruction and 
pharyngeal obstruction on SDB (24). It has frequently been observed by ourselves and 
others that the effect of INCS improves nasal related symptoms more consistently and 
effectively than sleep related objective measures such as the apnoea-hyponoea index and 
actigraphy measurements (unpublished data,20,24). Therefore effects of INCS on nasal 
inflammation may result in improvements in subjective sleep indices without improvements 
in objective sleep measures, supporting the concept of two co-existing conditions. One study 
undertook polysomnography pre and post pollen season in 25 subjects SAR and 25 normals 
Subjects with SAR showed a significant increase in symptoms (overall symptoms score 1.08 
± 2.7 at baseline compared with 21.3±13.1 in season) and also subjective increases in daytime 
sleepiness which only occurred in the moderate and severe SAR subjects. Objective sleep 
parameters showed an increase in objective sleep abnormalities, but the differences occurred 
within the normal range and were not felt to be of clinical relevance (26). This study tends to 
support the fact that RDS may be more significant in AR than other causes of SDB such as 
OSAS and insomnia. 
3. Mechanisms of sleep impairment in AR 
3.1 Nasal anatomy and physiology 
Introduction: The nose is an integrated part of the combined upper and lower airways both 
in function and inflammatory airways disease such as allergic rhinitis and asthma. There has 
been an increased focus on the significance of nasal breathing and it´s effect on health 
related quality of life and sleep during the last decade. Though easily accessible for 
examination, still little is known about how the regulation of nasal function is disturbed 
during inflammatory nasal disease. 
George Catlin, a famous American painter, who spent years living with the native north 
American Indians, found that the Indians did not sleep with an open mouth and he 
described the relationship between a patent nose and good sleep in his book “Shut your 
mouth and save your life” in 1832. Respiratory function during sleep is a dynamic process 
involving changes in respiratory drive, airway patency and in airway muscular tone during 
REM and non REM sleep which makes the relationship between nasal function and poor 
sleep complex and difficult to assess. Most studies addressing nasal patency in 
inflammatory airways disease have been performed in awake subjects sitting in the upright 
position. In reality the nasal mucosa is highly reactive and responds almost instantly to 
changes in temperature, humidity and a change in body position. In the evaluation of 
patients with sleep disturbances and allergic rhinitis several aspects of nasal anatomy and 
physiology thus have to be taken into account. 
External nose: The external nose protrudes from the bone aperture and is mainly composed of 
cartilage, muscle and subcutaneous fat apart from the two nasal bones at the top. The inside of 
the nasal openings and the anterior part of the nose is covered with skin and thus unaffected 
by nasal inflammation. The isthmus, is the narrow opening on the inside of the nose 
corresponding to the insertion of the nasal wings (alae) and the naso labial crest on the outside. 
More than half of the airway resistance is under normal conditions located here. During 
inspiration, the nasal openings tends to collapse as the passage of air through the narrow 
isthmus area put a suction force on the airway walls, the so called Bernouille effect. Patients 
with narrow nasal openings and weak alae are more prone to alar collapse especially when it 
combines with other abnormalities such as a septal deviation, turbinate hypertrophy or 
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inflammatory nasal disease. An activation of muscles in the anterior part of the nose help to 
counteract this tendency to collapse. When air is passed through the narrow isthmus with a 
high flow rate into the much larger nasal cavity where the flow rate is lower, the air flow 
becomes turbulent and disperses in a similar fashion to when water is expelled through a 
garden hose spray nozzle. Through this design the contact area between the air and the walls 
of the nasal cavity increases and enables the nose to effectively condition the inhaled air. 
The nasal cavities: The contact surface between the inhaled air and the mucous membrane is 
further enhanced by the folded structures on the lateral wall of the nasal cavity called the 
turbinates. There are three sets of turbinates in each nasal cavity. Most of the nasal cavity is 
encased in the skull bone and from an anterior view it is pyramid shaped. The inferior 
turbinates protrude into the airway at the base of the pyramid and an increase in the 
swelling of the mucosa covering the inferior turbinate can thus effectively obstruct the main 
nasal air flow like a cork seals a bottle neck. 
The nasal mucosa: The nasal respiratory mucosa replaces the skin starting at the head of 
the inferior turbinate and goes all the way to the nasopharynx. The nasal mucosa has 
major similarities with the respiratory mucosa of the bronchi and is today considered to 
be a linked functional organ with the lower respiratory tract which becomes evident in 
asthma and allergic inflammatory disease. The main difference is the presence of smooth 
muscle in the bronchi and the presence of sinusoids in the nose. Smooth muscle 
contraction can cause airway narrowing in the lungs which can be relieved with β-
agonists, but these drugs have no effect in the nose. Nasal patency is mainly regulated by 
variation of blood content in the erectile capacitance vessels called the sinusoids located in 
the sub mucosa. The regulation of nasal patency in the sinusoids is mediated through a 
neurovascular mechanism with different triggers such as air temperature, posture and 
physical exercise (27). Blood can be shifted in and out of the sinusoids through a rich 
capillary network equipped with artery-venous shunts. Nasal patency is maintained by a 
continuous sympathetic tone that can be up or down regulated. Increased sympathic 
activity during physical exercise or addition of adrenergic agonists increase nasal patency 
while a decrease in sympathetic activity decrease nasal patency as in Horner´s syndrome. 
In a third of the population “the nasal cycle” causes an alternating congestion and 
decongestion of the two nasal cavities going from one side to the other, a few hours apart. 
Nasal patency can also be changed by the application of pressure to the body surface. 
Unilateral pressure to the axillary region in the sitting position results in nasal congestion 
on the ipsilateral side and decongestion on the contralateral side, mediated via pressure 
sensitive receptors in the skin (28). A change in body position from sitting to supine also 
changes nasal patency, which may be important in regulating nasal patency during sleep 
as will be discussed in detail further down. 
Nasal function: Breathing through the nose conditions the inhaled air which increases in 
humidity and temperature. Particles are cleared and the immune system is activated against 
inhaled bacteria and viruses to protect the lungs. Nitric oxide from the nasal and sinus 
mucosa is added to the inhaled air which promotes the gas exchange in the lungs by 
enhancing the ventilator-perfusion ratio. During nasal exhalation humidity and energy is 
effectively recovered from the air compared to the oral route (29). Nasal function also 
includes the sense of smell and a loss of this function has a marked effect on both the ability 






but there is a shift to oral breathing at some point when developing nasal obstruction that 
varies individually. Oral breathing, apart from being less effective than the nose in air 
conditioning, also promotes airway collapse in oropharynx due to increased upper airway 
resistance (30). 
Assessing nasal patency: Objective measurements of changes in nasal patency can be 
obtained either as alterations in nasal air flow and resistance or as changes in intranasal 
diameter and volume. Rhinomanometry, nasal peak flow and nasal spirometry are 
examples of methods that give a good perception of the overall nasal air flow resistance but 
are less reliable to predict specific changes in the mucosa. Acoustic rhinometry or 
rhinostereometry are preferred when studying the variations in the nasal cavity dimensions 
due to swelling and decongestion at specific sites in the nasal cavity. For instance it has been 
shown that the minimal cross sectional area at 4 cm from the nostril is where the nasal 
mucosa decongests the most (31). Acoustic rhinometry, introduced by Hilberg in the 1980`s 
is by far the most widely used of the 2 methods and is quick to perform (32). Audible sound 
is lead into the nasal cavity and reflected back to generate a description of nasal cross 
sectional areas and volumes at different levels. Attempts have been made to correlate 
intranasal dimensions in healthy subjects to the subjective sensation of nasal patency, age, 
gender, BMI and head circumference without success. When used to compare changes in the 
same individual before and after an intervention, acoustic rhinometry has, however, proven 
accurate with a high reproducibility (33). In a recent review, Eccles found evidence for the 
benefit of septoplasty in studies using acoustic rhinometry, before and after surgery (34). 
3.2 Nasal function and sleep 
Nasal obstruction is considered the most important factor that links nasal inflammation to 
poor sleep but other factors such as the presence of inflammatory mediators affecting the 
CNS may also contribute. Nasal obstruction due to nasal inflammation is probably multi 
factorial including altered neurovascular control of the sinusoids, formation of sub mucous 
edema, secretion of excessive nasal secretions and cicardian changes following the serum 
cortisol cycle with a peak of nasal congestion in the morning. How these factors interact in 
nasal obstruction and how it affects sleep still remains unclear. This was recently reviewed 
by Craig and in summary, most studies showing a relationship between allergic rhinitis and 
poor sleep have focused on symptoms of nasal congestion rather than objective 
measurements of nasal patency during sleep (21). In a large north European multicentre 
study study we also found rhinitis to be an independent risk factor for sleep disturbances in 
asthma specifically in subjects reporting nasal symptoms every day (35). Studies looking at 
objective measures of nasal function are rare but Lavie et al found a an increased number of 
micro arousals during sleep in patients with allergic rhinitis during sleep (36) 
When regarding nasal congestion as a cause to poor sleep, one has to consider several options. 
If the nasal congestion is severe enough it leads to a shift into oral breathing and thus the 
effect on sleep is due to a change in breathing route. Effects of oral breathing on airway 
collapse and it´s relationship to OSAS goes beyond the focus of this chapter and will not be 
discussed here. If, however, nasal breathing is maintained during recumbent body position 
and sleep, it is necessary to consider both an increased airway resistance and changes to the 
neurovascular control of the nasal mucosa in relation to nasal inflammation. A relationship 
between nasal obstruction and sleep disordered breathing has been observed mainly on 
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subjects with oro pharyngeal narrowing in the awake situation and not in all patients with 
nasal obstruction, underlining that nasal obstruction is a co-factor affecting sleep in a 
complex way (37). With regard to the neurovascular regulation of the nasal mucosa, 
interesting data have emerged recently. Objective measurements of nasal patency during 
sleep are difficult to obtain without interfering with the sleep pattern. Lebowitz has 
described a study on 10 subjects doing consecutive acoustic rhinometry measurements 
during sleep while monitoring sleep stage. The results showed that nasal patency varies 
with sleep stage exhibiting a marked congestion during REM-sleep and decongestion 
during non-REM sleep (38). Variable nasal obstruction has been found to play a greater 
role in the pathophysiology of obstructive sleep apnea syndrome, than conditions 
associated with a fixed obstruction (39). In healthy subjects the nasal patency is typically 
reduced when going from sitting to supine body position measured with acoustic 
rhinometry (40). It has been suggested that this alteration of nasal patency supine is due 
to an increased hydrostatic pressure in the nasal vasculature supine and thus a passive 
mechanism (41). Ko measured heart rate variability as a measure of activity in the 
autonomic nervous system simultaneously with rhinomanometry between sitting and 
supine in 12 healthy subjects and found a significant correlation between decreased 
sympathetic activity supine followed by decreased nasal patency indicating an active 
regulation of nasal patency supine (42). In studies of patients with snoring and OSAS 
without rhinitis nasal geometry changes less or remain unchanged supine compared to 
healthy controls (43, 44). This could be related to an increased sympathic activity seen in 
this patient group (45). In fact an increased nasal obstruction or symptoms of nasal 
obstruction when lying down has been observed in patients with seasonal allergic rhinitis 
compared to controls, indicating an inflammatory up regulation of the neurovascular 
control of the nasal mucosa (46 47). 
We recently found no response with acoustic rhinometry to a change between sitting and 
supine in 19 patients with asthma and allergic rhinitis at inclusion, but a normalized 
reaction (with significantly decreased nasal patency supine) after 6 weeks treatment with a 
nasal steroid compared to placebo (unpublished data). Disturbances in the neurovascular 
control of the nasal mucosa supine is thus present in allergic rhinitis along with nasal 
obstruction and could interfere with nasal function during sleep but this has to evaluated 
further. 
4. Is there a definite relationship between nasal congestion and SDB?  
The relationship between subjective and objective measures of nasal obstruction are often 
poor which can confound studies in this area. Nasal obstruction is an independent risk 
factor for OSAS (9) but this is not confirmed in all studies. In normal subjects occlusion of 
the nose during the night causes an increase in sleep apnoea and transient arousals (50) 
suggesting that nasal obstruction irrespective of cause is an important cause of OSAS. In AR 
there is a general relationship between the presence and degree of nasal obstruction and 
obstructive sleep apnoea (8,50,51). This has also been confirmed in population studies (17). 
Anatomical deformities such as nasal septal deviation, adenoidal hypertrophy, nasal polyps 
are associated with SDB. However there are also other important predisposing factors for 






4.1 Does reversal of nasal obstruction also reverse the sleep disorder? 
Physical modalities of reversal of nasal obstruction include surgery to correct nasal septal 
deformity, removal of nasal polyps and adenoidectomy. The results of septoplasty in a 
randomised control trial (52) showed that only a subgroup (15%) benefited in terms of 
improved OSAS. This is consistent with other studies which often show improvements in 
some indices eg less sleepiness, better QOL but no changes in the apnoea-hypopnoea index 
(53). This suggests that OSAS is multifactorial and alleviation of nasal obstruction is only a 
partial solution. Tonsillectomy and adenoidectomy in children with OSAS can result in 
complete resolution of symptoms but results are variable between studies with success rates 
of 27-87% reported (54, 55). 
The use of nasal dilators has been examined in 5 studies and has provided equivocal results. 
Breathe Rite nasal strips: these increase PNIF by a mean of 26L/min and also significantly 
improve the respiratory index (56) 
4.2 Medical treatment for nasal congestion as treatment for SDB 
Antihistamines (oral or topical) have less effect on nasal congestion than INCS or 
decongestants but have been shown to be helpful in improving sleep in some studies (57) 
Oral decongestants do reduce nasal congestion but this is not accompanied by 
improvements in sleep quality probably due to the side effects of pseudoephedrine (58). 
Topical decongestants also reduce nasal obstruction and improve sleep but are never 
recommended for long term use due to the risk of developing rhinitis medicamentosa (59) 
Leukotriene receptor antagonists are an effective treatment for SAR providing 
improvements in nasal congestion and also some improvements in sleep impairment (60). 
The first line of treatment when treating nasal obstruction in allergic rhinitis with or without 
concomitant asthma according to the evidence based guidelines Allergic rhinitis and its 
impact on asthma (ARIA) is intranasal steroids (48). The evidence is 1A for alleviating nasal 
congestion but nasal steroids also reduce other symptoms of nasal inflammation such as 
itching, sneezing and secretion along with a reduction of ocular symptoms (49). This is 
accompanied by improved QOL. In allergic rhinitis patients treated with nasal steroids 
improved significantly in self reported quality of sleep but not in objective sleep measured 
with polysomnography and actigraphy (19,24). 
5. Results of current research 
We recently conducted a study utilising objective measures of nasal patency (PNIF, acoustic 
rhinometry) and sleep parameters (actigraphy) in subjects with mild asthma and PAR. The 
effect of INCS was also determined. 
Nineteen patients with asthma and allergic rhinitis were assessed before and after 6 weeks 
treatment with an intranasal steroid spray (fluticasone propionate) versus 6 weeks of 
placebo nasal spray in a double blind cross over design (unpublished data). Nasal patency 
was measured with acoustic rhinometry sitting and supine and objective quality of sleep 
was measured with actigraphy. Actigraphy measures limb movements during sleep and has 
been validated against polysomnography. While actigraphy failed to show any 
improvement in sleep quality after nasal steroid treatment, there was a significant 
improvement in rhinitis specific health related quality of life measured with the rhinitis 
quality of life questionnaire (RQLQ). More importantly we found no change in nasal 
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patency between sitting and supine at baseline, indicating an impaired neurovascular 
control. After 6 weeks treatment with a nasal steroid the nasal reactivity between sitting and 
supine returned to normal, showing a significant decrease supine compared to sitting. 
According to ARIA the evidence shows that even though oral antihistamines and 
leukotriene antagonists have an effect on several symptoms of allergic rhinitis, nasal steroids 
are the most effective in treating nasal congestion. Our data suggest that nasal steroids also 
restore neurovascular control in the nasal mucosa, a mechanism that is involved in the 
adaptation of nasal patency between sitting and supine and in the variation of nasal 
congestion during sleep. Larger studies are still needed to establish how neurovascular 
control is affected during wakefulness and during sleep and how nasal obstruction and 
impaired nasal function interact in patients with allergic rhinitis. 
6. Summary 
Nasal inflammation in allergic rhinitis adversely affects sleep. Nasal congestion is believed 
to be one of the more important factors based on self reported data and a limited number of 
studies evaluating nasal function before and after anti inflammatory treatment. 
Neurovascular dysfunction in the regulation of nasal patency and circulating inflammatory 
mediators may also contribute to disturbed sleep along with other rhinitis symptoms such 
as itching and sneezing. Nasal steroids are effective in treating allergic rhinitis and 
contribute to reducing symptoms of poor sleep. The causes of SDB in Ar are likely to be 
multifactorial and include a newly named entity RDS. The specific mechanisms behind 
allergic rhinitis and poor sleep warrant further examination. 
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